Asthma therapy for the 21st century

Article Abstract:

A symposium on asthma therapy development for the 21st century was held at the National Heart and Lung Institute, London, UK. It highlighted current therapy consisting of beta-2-adrenoceptor agonists, theophylline and glucocorticosteroids and efforts to develop new anti-inflammatory therapy for asthma. There is an ongoing development of a second generation theophyllines that inhibit phosphodiesterase to lessen side effects while retaining its beneficial action.

Research, Adrenergic beta agonists, Adrenergic beta-agonists, Theophylline

---

NF-kB: a pivotal role in asthma and a new target for therapy

Article Abstract:

The prevalence and morbidity of asthma, a chronic inflammatory disease of the airways, have been increasing. Studies have shown that many of the stimuli that heighten inflammation in asthmatic airways lead to the activation of NF-kB, a factor that plays an important role in immune and inflammatory responses. The inhibition of NF-kB should present a new focus for the development of new anti-inflammatory drugs for asthma.

Product development

---

Reply: 5-HT(sub)1A receptors and control of airways

Article Abstract:

This article discusses the role of 5-HT(sub)1A receptors in inducing anti-asthmatic effect. Results suggest that intravenous administration of receptor antagonists cause bronchodilation of the obstructed airways.

Italy, United States, Brief Article, Letter to the Editor, Bronchodilator agents, Bronchodilator agent structure-activity relationships

Similar abstracts:

• Abstracts: Pharmacological prospects for alpha2-adrenoceptor antagonist therapy. Application of in situ microdialysis to measure metabolic and vascular responses in adipose tissue
• Abstracts: Antispasmodic effect of the essential oil of Plectranthus barbatus and some major constituents on the guinea-pig ileum
• Abstracts: Diterpenes from the aerial parts of Salvia candelabrum and their protective effects against lipid peroxidation
• Abstracts: Cloning of a 'D3' receptor subtype expands dopamine receptor family. P2Y receptors: in the middle of the road
• Abstracts: Insight into adenosine receptor function using antisense and gene-knockout approaches. Reply: a sanguine approach to cannabis

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.